Cited 0 time in
Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chau, Angela | - |
| dc.contributor.author | Yeh, Ming-Lun | - |
| dc.contributor.author | Tsai, Pei-Chien | - |
| dc.contributor.author | Huang, Daniel Q. | - |
| dc.contributor.author | Kim, Sung Eun | - |
| dc.contributor.author | Trinh, Huy | - |
| dc.contributor.author | Yoon, Eileen L. | - |
| dc.contributor.author | Oh, Hyunwoo | - |
| dc.contributor.author | Jeong, Jae Yoon | - |
| dc.contributor.author | Ahn, Sang Bong | - |
| dc.contributor.author | An, Jihyun | - |
| dc.contributor.author | Tseng, Cheng-Hao | - |
| dc.contributor.author | Hsu, Yao-Chun | - |
| dc.contributor.author | Jeong, Soung Won | - |
| dc.contributor.author | Cho, Yong Kyun | - |
| dc.contributor.author | Shim, Jae-Jun | - |
| dc.contributor.author | Kim, Hyoung Su | - |
| dc.contributor.author | Ito, Takanori | - |
| dc.contributor.author | Marciano, Sebastián | - |
| dc.contributor.author | Kawashima, Keigo | - |
| dc.contributor.author | Suzuki, Takanori | - |
| dc.contributor.author | Watanabe, Tsunamasa | - |
| dc.contributor.author | Nozaki, Akito | - |
| dc.contributor.author | Ishikawa, Toru | - |
| dc.contributor.author | Inoue, Kaori | - |
| dc.contributor.author | Eguchi, Yuichiro | - |
| dc.contributor.author | Uojima, Haruki | - |
| dc.contributor.author | Abe, Hiroshi | - |
| dc.contributor.author | Takahashi, Hirokazu | - |
| dc.contributor.author | Chuma, Makoto | - |
| dc.contributor.author | Ishigami, Masatoshi | - |
| dc.contributor.author | Hoang, Joseph K. | - |
| dc.contributor.author | Maeda, Mayumi | - |
| dc.contributor.author | Huang, Chung-Feng | - |
| dc.contributor.author | Gadano, Adrian | - |
| dc.contributor.author | Dai, Chia-Yen | - |
| dc.contributor.author | Huang, Jee-Fu | - |
| dc.contributor.author | Tanaka, Yasuhito | - |
| dc.contributor.author | Chuang, Wan-Long | - |
| dc.contributor.author | Lim, Seng Gee | - |
| dc.contributor.author | Cheung, Ramsey | - |
| dc.contributor.author | Yu, Ming-Lung | - |
| dc.contributor.author | Jun, Dae-Won | - |
| dc.contributor.author | Nguyen, Mindie H. | - |
| dc.date.accessioned | 2024-11-28T19:01:15Z | - |
| dc.date.available | 2024-11-28T19:01:15Z | - |
| dc.date.issued | 2024-03 | - |
| dc.identifier.issn | 1542-3565 | - |
| dc.identifier.issn | 1542-7714 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/198138 | - |
| dc.description.abstract | Background & Aims: It is unclear if there may be sex differences in response to nucleos(t)ide analogs including virologic response (VR), biochemical response (BR), complete response (CR), and hepatocellular carcinoma (HCC) incidence among hepatitis B patients. We compared nucleos(t)ide analog treatment outcomes by sex. Methods: We performed a retrospective cohort study of 3388 treatment-naïve adult hepatitis B patients (1250 female, 2138 male) from the Real-World Evidence from the Global Alliance for the Study of Hepatitis B Virus consortium who initiated therapy with either entecavir or tenofovir from 22 sites (Argentina, Korea, Japan, Taiwan, and the United States). We used propensity-score matching to balance background characteristics of the male and female groups and competing-risks analysis to estimate the incidence and subdistribution hazard ratios (SHRs) of VR, BR, CR, and HCC. Results: Females (vs males) were older (52.0 vs 48.6 y); less likely to be overweight/obese (49.3% vs 65.7%), diabetic (9.9% vs 13.1%), or cirrhotic (27.9% vs 33.0%); and had a lower HBV DNA level (5.9 vs 6.0 log10 IU/mL) and alanine aminotransferase level (91 vs 102 IU/L) (all P <.01). However, after propensity-score matching, relevant background characteristics were balanced between the 2 groups. Females (vs males) had similar 5-year cumulative VR (91.3% vs 90.3%; P =.40) and HCC incidence rates (5.1% vs 4.4%; P =.64), but lower BR (84.0% vs 90.9%; P <.001) and CR (78.8% vs 83.4%; P =.016). Males were more likely to achieve BR (SHR, 1.31; 95% CI, 1.17–1.46; P <.001) and CR (SHR, 1.16; 95% CI, 1.03–1.31; P =.016), but VR and HCC risks were similar. Conclusions: Sex differences exist for treatment outcomes among hepatitis B patients. Male sex was associated with a 16% higher likelihood of clinical remission and a 31% higher likelihood of biochemical response than females, while virologic response and HCC incidence were similar between the 2 groups. | - |
| dc.format.extent | 9 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | W. B. Saunders Co., Ltd. | - |
| dc.title | Sex Differences in Treatment Response to Nucleos(t)ide Therapy in Chronic Hepatitis B: A Multicenter Longitudinal Study | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1016/j.cgh.2023.09.002 | - |
| dc.identifier.scopusid | 2-s2.0-85175712353 | - |
| dc.identifier.wosid | 001198134700001 | - |
| dc.identifier.bibliographicCitation | Clinical Gastroenterology and Hepatology, v.22, no.3, pp 572 - 580 | - |
| dc.citation.title | Clinical Gastroenterology and Hepatology | - |
| dc.citation.volume | 22 | - |
| dc.citation.number | 3 | - |
| dc.citation.startPage | 572 | - |
| dc.citation.endPage | 580 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
| dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
| dc.subject.keywordPlus | RISK | - |
| dc.subject.keywordPlus | AGE | - |
| dc.subject.keywordAuthor | Antiviral Therapy | - |
| dc.subject.keywordAuthor | Biochemical Response | - |
| dc.subject.keywordAuthor | Complete Response | - |
| dc.subject.keywordAuthor | Virologic Response | - |
| dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1542356523007139?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
